Company Active LTD

Company profile

Biosynth Limited

Biosynth Limited is a UK company with status active founded in 2006 based in South East England.

CRN
05771788
Founded
2006
Age
20

Overview

Legal name
BIOSYNTH LIMITED
Region
South East England
Registered address
8 & 9 OLD STATION BUSINESS PARK
COMPTON
NEWBURY
BERKSHIRE
RG20 6NE
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

2 levels 1 ultimate controller Controls 1
1
Company Active LTD
Biosynth Limited
CRN 05771788
2
Direct controller Active LTD
3
Ultimate controller
CHE-102.768.414
CRN CHE-102.768.414

Company events

Reference milestones and recent Companies House filing stream events.

9 events
02 May
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

18 Apr
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

25 Feb
2025

Appoint Person Secretary Company With Name Date

Officers

AP03 | Transaction MzQ1NjI5ODg3MWFkaXF6a2N4

Published 25 Feb 2025 09:39

25 Feb
2025

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQ1NjI5ODU0OGFkaXF6a2N4

Published 25 Feb 2025 09:36

25 Feb
2025

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQ1NjI5ODQ1OWFkaXF6a2N4

Published 25 Feb 2025 09:36

25 Feb
2025

Termination Secretary Company With Name Termination Date

Officers

TM02 | Transaction MzQ1NjI5ODQwN2FkaXF6a2N4

Published 25 Feb 2025 09:35

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

06 Apr
2006

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2012
Funded years
2012
Age at first award
6 years

Projects

2012 Collaborative R&D

New filtration technologies for antibody removal from donated blood components (SANGUIS)

1 Dec 2012 to 31 Aug 2016

Awarded
£121,993
Total cost £243,942

The feasibility of developing a new blood filter incorporating novel 'Hydrospace' textile technology containing pre-encapsulated binders for the selective removal of harmful antibodies in donated blood plasma has been proven in a 2011 TSB-funded feasability study. This project will further develop a robust, high quality, NHS-approved filter which is effec...

Product types

Collaborative R&D